A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation

Zhao, KX; Zhang, YF; Zheng, L; Pan, YF; He, ZH

He, ZH (通讯作者)，Zhejiang Hosp, Dept Vasc Surg, 12 Lingyin Rd, Hangzhou 310013, Zhejiang, Peoples R China.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2023; 46 (12): 551

Abstract

Background:Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors are standard therapy for patients with non-small cell lung cancer (NSCLC......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索